X enotransplantation of pig organs offers the best near-term solution for relieving the current shortage of transplantable allogeneic solid organs. However, the acquired immune response is considerably stronger to xenografts than it is to allografts, at the levels of both antibody and T cell immune responses, [1] [2] [3] [4] suggesting that clinically relevant levels of conventional immunosuppression will be inadequate to prevent acquired immune rejection of solid organ xenografts.
Both stable and transient lymphohematopoietic chimerisms have been demonstrated to be capable of inducing tolerance of solid organ transplants. Thus, studies in murine 5 and porcine 6 animal models and in recent clinical trials 7 have demonstrated that the establishment of stable allogeneic mixed lymphohematopoietic chimerism leads to transplantation tolerance of donor organs across MHC barriers. In nonhuman primate models [8] [9] [10] and HLA-mismatched clinical trials, 11, 12 tolerance of allogeneic solid organ grafts has also been achieved in conjunction with establishment of transient mixed lymphohematopoietic chimerism.
Extension of these modalities to xenografts has been limited to date by the rapid macrophage-mediated clearance of porcine hematopoietic cells (HC) from the primate circulation, precluding the establishment of either stable or transient chimerism of substantial duration and degree. [13] [14] [15] A likely reason for this clearance is that inhibition of phagocytosis through macrophage signal regulatory protein α receptor binding of CD47 on HC does not occur in the pig/primate combination. 16, 17 Consistent with this hypothesis, we have previously demonstrated that transgenic expression of human CD47 (hCD47) substantially increases HC engraftment in a murine model of pig-to-human cell transplantation.
In this study, we report that transgenic expression of hCD47 on HC of α-1,3-galactosyltransferase knockout pigs substantially increases the duration of transient xenogeneic chimerism after HC transplantation to baboons. Additionally, prolonged transient chimerism in this model is associated with acceptance of porcine skin grafts for up to 2 months in the absence of concurrent immunosuppression.
MATERIALS AND METHODS

Animals
Baboon recipients were male Papio Hamadrayas (n = 5) of 5 to 6 kg and 2 to 3 years of age (Mannheimer Foundation, Homestead, FL). All recipients were selected for low pretransplant anti-non-Gal cytotoxic antibody levels. The derivation of cloned hCD47 transgenic pig 18286 was previously described 18 ; transgenic pig 18289 was derived in an identical fashion and the genotype confirmed also as described. All animal works were conducted in accordance with the National Institutes of Health and the United States Department of Agriculture guidelines and with approval from the MGH Institutional Animal Care and Use Committee.
FACS Analysis of hCD47
Cell surface expression of hCD47 was detected using PE or AlexaFluor 647 conjugated mouse-anti-hCD47 clone B6H12 (BD Biosciences) on heparinized whole blood or peripheral blood mononuclear cells. Acquisition was performed on a Substitute Flow Cytometry Calibur (Becton-Dickinson, Mountain View, CA) and analyzed using FloJo software (Treestar, Ashland, OR).
Hematopoietic Progenitor Cell Isolation and Transplantation
Peripheral blood stem and progenitor cells from hCD47 transgenic swine were obtained at 9 to 11 months of age by leukapheresis after mobilization for 6 days with porcine IL-3 and porcine stem cell factor (SCF) as previously described. 19 Low-density cells from the leukapheresis product were isolated by gradient centrifugation over Histopaque (Sigma, St. Louis, MO), diluted to P = 1.070. Low-density cells were enriched for the ckit+ population using biotinylated porcine SCF as previously described. 20 The degree of enrichment was assessed by flow cytometry using biotinylated SCF and streptavidin conjugated AlexaFluor 647. High-density cells (lymphocytes) were also isolated by gradient centrifugation over Histopaque (Sigma) diluted to P = 1.077.
Baboons were conditioned with a nonmyeloablative regimen. The regimen consisted of T cell depletion with 250 cGy total body irradiation, 700 cGy of thymic irradiation, 2 doses of a monoclonal anti-CD2 antibody (loCD2b), and 1 dose of 50 mg/kg equine antithymocyte globulin (ATGam; Pfizer). B cell depletion was achieved with 1 dose of anti-CD20 (Rituxan, Genentech) 20 mg/kg 9 days before cell infusion on day 0.
Animals received a continuous infusion of tacrolimus maintenance therapy from day 3 to day 28, through indwelling intravenous catheters, after which the immunosuppression was discontinued, and the intravenous catheters removed. The dose of tacrolimus was 0.1 mg/kg per day to achieve a target blood level of 5 to 10 ng/mL. Anti-CD154 (CD40L) costimulatory blockade was administered at 20 mg/kg on days −1, 1, 3, and 5, then weekly through 7 weeks. Methylprednisolone (Solu-Medrol) at 4 mg/kg was given twice per day from day 0 to day 2. Splenectomy was performed on day −10, at the time of catheter placement. All baboons received prostacyclin and heparin to prevent thrombotic microangiopathy, cytomegalovirus prophylaxis with Ganciclovir, and prophylactic levofloxacin and cefepime.
Isolated hCD47 high-expressing or low-expressing porcine progenitor cells (ckit+) and lymphocytes from the leukapheresis product were intravenously infused into groups 1 and 2 baboon recipients, respectively, on day 0, with additional infusions 7 and 9 weeks later. The second and third cell infusions consisted of unfractionated total leukapheresed porcine cells that were frozen at the time of collection from the transgenic donors. The control baboon received only the conditioning and maintenance regimen.
Assessment of Peripheral Blood Chimerism
Pig cells were assessed in recipient peripheral blood as previously described. 15 Briefly 100 μL of whole blood was stained with a biotinylated pig-specific antibody which does not cross-react with baboon, followed by detection with phycoerythrin streptavidin and an APC-conjugated mouse antihuman CD45 clone D058-1283 (BD Biosciences). 1030H-1-10-positive cells not stained by antihuman CD45 mAb were considered to be of porcine origin. Acquisition was performed on a FACSCalibur and propidium iodide excluding cells within the lymphocyte gate analyzed using FloJo software. Standard deviation of the mean was calculated using Prizm software.
Skin Graft Transplantation
Donor swine were premedicated with atropine 0.04 mg/kg and xylazine 1 mg/kg, and sedated with telazol 2 mg/kg intramuscularly (IM), before maintenance anesthesia with inhaled isoflurane 1% to 5% in oxygen. After antiseptic skin preparation with 2% (w/v) chlorhexidine acetate (Nolvasan Surgical Scrub; Fort Dodge Animal Health, Fort Dodge, IA), 70% isopropyl alcohol (Owens & Minor, Mechanicsville, VA), and 10% povidone-iodine (Betadine Solution; Purdue Products, Stamford, CT) split-thickness skin grafts (STSG) were harvested from the flank using an air-driven dermatome (Zimmer U.K. Ltd, Wiltshire, UK). Grafts were immediately placed in 0.9% normal saline, and transferred directly to the recipient table for transplantation. Skin graft recipient baboons were premedicated with atropine 0.04 mg/kg IM and sedated with ketamine 20 mg/kg IM. Dorsal hair was shaved, and after endotracheal intubation, animals were placed in the prone position. Skin preparation was as above, and fullthickness recipient wound beds were prepared by excision of dorsal skin and subcutaneous tissue down to dorsal muscle, inferior to the level of the scapulae. After meticulous hemostasis with electrocautery and anchoring of the wound margins to underlying muscle with absorbable suture, skin xenografts and/or allograft controls were then transplanted and secured with simple interrupted nylon sutures and absorbable quilting sutures. Grafts were dressed with bacitracin, nonadherent telfa gauze, and adherent tegaderm to achieve compression and protection from sheer forces. The animals were then placed in jackets to protect the grafts. Dressings were changed on posttransplant day 2 and alternate days thereafter, and sutures were removed on posttransplant day 14.
Skin Graft Assessment
Skin graft appearance was documented by serial photography and grafts determined to be rejected when less than 10% of the original graft remained viable. Periodic graft biopsies were performed under sedation and local anesthesia using a 3-mm diameter biopsy punch. Biopsies were taken down to underlying muscle to ensure inclusion of full-depth graft tissue in each sample. Hemostasis and wound closure was achieved with 3/0 nylon suture dressings applied as described above. Specimens were fixed in 10% formalin, sectioned and stained with hematoxylin and eosin for assessment and scoring, unblinded, by a board-certified pathologist.
RESULTS Variable Expression of the hCD47 Transgene in Genetically Identical Cloned Pigs
We previously reported the generation of a cloned transgenic miniature swine (18286) on an α-1,3-galactosyltransferase null background by recloning from a transgenic fetus (846-2). 18 Both the fetus and 18286 demonstrated uniform expression of hCD47 on HC and fibroblasts. Despite recloning from the same fetus, a second transgenic pig (18289) demonstrated very low hCD47 transgene expression on peripheral blood mononuclear cells ( Figure 1A ). Marked differences in transgene expression after cloning and nuclear transfer have been reported previously, 21 although the basis for this phenomenon remains unclear. Nevertheless, the availability of these 2 otherwise identical animals offered us the unique opportunity to determine whether the level of expression of hCD47 on porcine HC would affect their clearance from the primate circulation. To test the hypothesis that expression of hCD47 would inhibit primate clearance of porcine HC, we transplanted cells from transgenic pigs 18286 and 18289 into baboons. Mobilized peripheral blood stem cells (PBSC) from these transgenic swine were used as the source of PBSC, and cells from each animal were transplanted into 2 baboons conditioned with a preparative regimen that included low-dose whole body irradiation and lymphocyte depletion. 22 Recipient baboons B337 and B342 received PBSC from the hCD47 high-expressing pig 18286, which demonstrated uniform expression of hCD47 in the mobilized PBSC population. 18 Baboons B370 and B371 received cells from low-expressing pig 18289. Transplantation of PBSC was performed immediately after conditioning (day 0), and additional challenge infusions from the same swine were administered 7 and 9 weeks later. Immunosuppression consisted of calcineurin inhibition and T cell costimulatory blockade with an anti-CD154 mAb for the first 4 weeks, anti-CD154 mAb only for the next 3 weeks and no immunosuppression thereafter. Both baboons receiving PBSC from donor 18286 demonstrated readily detectable macrochimerism in peripheral blood for several days after the initial cell transplant and after both subsequent cell infusions ( Figures 1B, C) . In contrast, chimerism was rapidly lost in the baboons receiving PBSC from donor 18289 and was undetectable by 1 day after infusion, consistent with FIGURE 1. hCD47 transgene expression in porcine cells correlates with prolonged peripheral chimerism in baboon recipients. A, hCD47 expression differs dramatically between genetically identical transgenic cloned swine. hCD47 expression on peripheral blood mononuclear cells from cloned transgenic swine 18286, 18289 and a wild type control. Uniform expression of the transgene was observed in 18286, whereas expression was limited to a small fraction of PBMC in 18289. B, Peripheral blood levels of porcine leukocytes following transplantation into baboon recipients immediately after conditioning (first cell infusion, day 0), 7 weeks later (second cell infusion), and 9 weeks later (third cell infusion). B337 and B342 received PBSC from hCD47 transgenic donor 18286; B370 and B371 received PBSC from transgenic donor 18289. Day 0 samples were obtained 5 hours after the first cell infusion and 1 hour after the second and third cell infusions. C, Representative FACS analyses of day 1 samples after the first cell infusion in B342 and in B371. Porcine cells were detected in whole blood staining as those staining positively with anti-pan swine monoclonal antibody 1030H-1-19 and negatively with primate anti-CD45 antibody. The absolute number of porcine leukocytes per ml was derived by multiplying the percent chimerism by the white blood cell count.
previously reports of porcine HC clearance after infusion into primates.
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Prolongation of Hematopoietic Chimerism Is Associated With Markedly Prolonged Survival of Donor Swine Skin Xenografts in the Absence of Immunosuppression
We next asked whether the HSC transplants might have affected recipient responses to tissue transplants from the donor swine. STSG from the transgenic PBSC donors were placed onto full-thickness graft beds at 14 weeks after the initial cell transplants on the 4 baboons, by which time, all exogenous immunosuppression had been discontinued for over 4 weeks. A control baboon (B360) received identical conditioning and immunosuppression regimens, but no cell transplants. Grafts were observed every 2 to 3 days and considered rejected when apparently viable tissue comprised less than 10% of the entire graft area.
The gross appearance of the skin grafts on baboons B337, B370, and B360 is shown in Figure 2 . Grafts on all recipients were initially adherent and showed signs of vascularization and bruising over the first 4 days. The graft on B337, which received HSC transplants from high hCD47 expressing swine donor 18286, showed small islands of healthy tissue, which subsequently expanded and coalesced, to cover the entire area of the full-thickness graft bed with healthy porcine skin by day 42. We observed the continuing appearance of healthy porcine tissue covering the entire full-thickness graft bed, without contraction of the graft bed, for over 53 days after STSG placement, at which point the entire graft had the appearance of normal, healthy porcine skin. The appearance of the graft deteriorated slowly over the following 2 weeks, reaching less than 10% viable epidermis by visual inspection on day 70. An allogeneic skin graft on B337 also showed prolonged survival but with progressive, marked contraction of the graft and graft bed and with histologic evidence of severe cellular rejection. The second recipient of cells and skin from the hCD47 uniform expressing donor (B342) followed a similar time course for the first 23 days postgrafting, but then developed signs of local wound infection, leading to graft loss, with histologic evidence of bacterial colonization, by day 33. In marked contrast, grafts on both recipients of HSC transplants from low hCD47-expressing swine donor 18289 (B370 and B371) and the control recipient (B360) were judged clinically rejected by day 14.
Histological examination of the porcine graft on B337 at 53 days revealed completely normal dermal and epidermal structure, with only a mild, eosinophil-rich, cellular infiltrate in the dermis ( Figure 3A) . Biopsies on day 67 showed extensive dermal infiltration characteristic of grade 4 rejection and epidermal loss.
Consistent with their early rejection, biopsies from the low hCD47 recipients and the control recipient all showed complete loss of epidermis and extensive dermal necrosis accompanied by FIGURE 2. Transient porcine chimerism leads to prolonged survival of porcine skin grafts on baboon recipients in the absence of immunosuppression. Top: timeline of cell infusions, immunosuppressive therapy and skin grafting for these experiments. Bottom: photographs of split thickness porcine skin grafts on the indicated day after graft placement. B337 and B342 received cell and skin transplants from hCD47 transgenic swine 18286 (high hCD47 expression), while B370 received cells and skin from swine 18289 (low hCD47 expression). B360 received the same conditioning regimen and a skin graft from 18289, but no cell transplants. All grafts initially showed signs of vascularization (marked by bruising). In recipient B337, healthy appearing islands of porcine skin gradually expanded to fill the entire graft bed. B342 showed a graft course similar to that observed in B337, but the graft was lost to infection before substantial epidermal expansion. In contrast, B370 and B360 completely rejected their grafts within 10 to 14 days.
polymorphonuclear infiltration consistent with a necrotic process by day 10 ( Figure 3B ). In stark contrast, biopsies of high hCD47 recipients B337 and B342 at days 14 and 19, respectively, revealed a well-maintained dermis with areas of reepithelialization and no cellular infiltrate. Capillaries with reactive endothelium were also observed in these recipients, but absent from the early rejecting recipients. We have no evidence to suggest that preexisting antibodies are involved in early rejection, because all recipients had at most barely detectable cytotoxic IgM levels, and no cytotoxic IgG, through the first 10 to 14 days after skin grafting ( Figures S1 and S2 , SDC, http://links.lww.com/TP/B283).
DISCUSSION
These results indicate a strong correlation between hCD47 expression, prolonged peripheral porcine chimerism, and marked prolongation of porcine skin grafts in the absence of concurrent immunosuppression. Previous in vitro studies 23, 24 and in vivo murine studies 18, 25, 26 with hCD47-expressing cells, as well as macrophage depletion studies in primates, [13] [14] [15] strongly suggest that inhibition of reticuloendothelial engulfment is responsible for the prolonged chimerism, but direct demonstration of this in a primate model is difficult to obtain and awaits further studies. Because the control animal and all 4 recipients of PBSC had received the same immunosuppressive regimen and because skin grafts were placed more than 4 weeks after all immunosuppression had been discontinued, the most likely explanation for prolongation of skin graft survivals in B337 and B342 is a systemic immune modulating effect of the transient mixed chimerism in these recipients.
Dissection of the immune mechanisms involved in prolonged xenogeneic skin survival will require additional investigation. A detailed serial examination of histology in future recipients at the level of the graft bed over the first week may provide insight into the mechanism by which hCD47 high recipients B337 and B342 were able to avoid complete epidermal loss and dermal necrosis. Understanding the mechanisms involved in late graft loss will also benefit from serial examination during the rejection period in future recipients. With the exception of an eosinophilic infiltrate, no suggestion of a rejection process was evident in biopsies of B337 at day 53 after grafting. The following biopsy, taken at the first overt clinical signs of graft degradation on day 67, revealed grade 4 rejection with extensive acute and chronic infiltration and as such was uninformative with respect to potential mechanisms of graft loss. Whether in addition to prolonging peripheral chimerism, hCD47 has a role within the graft itself also needs to be examined. This can be best addressed in recipients conditioned with hCD47 high cells followed by simultaneous skin grafting from the hCD47 cell donor and a congenic, nontransgenic control. The inbred, MHC-defined miniature swine used in this study will therefore provide a unique opportunity to examine the role of graft expression of hCD47 in this manner.
Prolongation of skin graft survival is generally considered the most stringent test for immunosuppressive or toleranceinducing regimens in the field of transplantation. 19, 27, 28 Although full durable tolerance was not achieved in this study, it nonetheless presents the first demonstration of the efficacy of HC transplantation in providing an immune modulating effect for porcine grafts transplanted to primate recipients. Previous primate studies have demonstrated good preservation of graft architecture and function for over 100 days after life-sustaining transplantation of porcine kidneys 29 and for over 1-year after heterotopic transplantation of porcine hearts. 30 Graft survival in these cases required continuous administration of multiple immunosuppressive agents, including frequent infusion of T cell costimulation-blocking FIGURE 3. A, Histological examination confirms the reestablishment of normal dermal and epidermal structure at 53 days after porcine skin transplantation. H&E staining of the porcine graft on B337 53 days after transplantation revealed some eosinophilic infiltration, but no classical signs of rejection. Biopsy on day 67 revealed extensive dermal acute and chronic inflammation with epidermal loss. B, Reepithelialization and maintenance of dermal viability in recipients B337 and B342. H&E staining of biopsies from hCD47 high recipients B337 and B342 at days 14 and 19 respectively revealed areas of re-epithelialization (arrows), including migration along a hair follicle in B342 (inset). No cellular infiltration was observed in the graft for either recipient. In contrast, complete loss of epidermis, with dermal necrosis and cellular infiltration was seen in B370 and B360 at days 10 and 7 respectively. H&E, hematoxylin-eosin.
antibodies. Long-term graft maintenance under such conditions would likely be associated with high rates of serious or fatal infections and lymphoproliferative disease, limiting potential clinical applicability. In this study, recipients received prophylactic antibiotic and antiviral agents for the first month of conditioning, but required no therapeutic agents thereafter and in all cases maintained excellent health throughout the study. Thus, the 2-month survival of a porcine skin graft after the withdrawal of all immunosuppression reported here strongly suggests that HC conditioning may allow for longterm xenograft function in conjunction with a clinically acceptable maintenance regimen. If this result can be extended successfully to vascularized organ xenotransplants, it could greatly expand the number of life-sustaining organs available for transplantation.
